Montgomery Morgan L, Gross Caroline R, Lin Hung-Mo, Ouyang Yuxia, Levin Matthew A, Corkill Holly E, El-Eshmawi Ahmed, Adams David H, Weiner Menachem M
Department of Anesthesiology, Perioperative and Pain Medicine, Icahn School of Medicine at Mount Sinai, New York, NY.
Department of Anesthesiology, Perioperative and Pain Medicine, Icahn School of Medicine at Mount Sinai, New York, NY.
J Cardiothorac Vasc Anesth. 2023 Mar;37(3):367-373. doi: 10.1053/j.jvca.2022.11.019. Epub 2022 Nov 22.
To describe the trend in plasma renin activity over time in patients undergoing cardiac surgery on cardiopulmonary bypass, and to investigate if increased plasma renin activity is associated with postcardiopulmonary bypass vasoplegia.
A prospective cohort study.
Patients were enrolled from June 2020 to May 2021 at a tertiary cardiac surgical institution.
A cohort of 100 adult patients undergoing cardiac surgery on cardiopulmonary bypass.
None.
Plasma renin activity was measured at 5 time points: baseline, postoperatively, and at midnight on postoperative days 1, 2, and 3. Plasma renin activity and delta plasma renin activity were correlated with the incidence of vasoplegia and clinical outcomes. The median plasma renin activity increased approximately 3 times from baseline immediately after cardiac surgery, remained elevated on postoperative days 0, 1, and 2, and began to downtrend on postoperative day 3. Plasma renin activity was approximately 3 times higher at all measured time points in patients who developed vasoplegia versus those who did not.
In patients undergoing cardiac surgery on cardiopulmonary bypass, plasma renin activity increased postoperatively and remained elevated through postoperative day 2. Additionally, patients with vasoplegic syndrome after cardiac surgery on cardiopulmonary bypass had more robust elevations in plasma renin activity than nonvasoplegic patients. These findings support the need for randomized controlled trials to determine if patients undergoing cardiac surgery with high plasma renin activity may benefit from targeted treatment with therapies such as synthetic angiotensin II.
描述接受体外循环心脏手术患者血浆肾素活性随时间的变化趋势,并研究血浆肾素活性升高是否与体外循环后血管麻痹相关。
前瞻性队列研究。
2020年6月至2021年5月在一家三级心脏外科机构招募患者。
一组100例接受体外循环心脏手术的成年患者。
无。
在5个时间点测量血浆肾素活性:基线、术后、术后第1、2、3天午夜。血浆肾素活性和血浆肾素活性变化值与血管麻痹发生率及临床结局相关。心脏手术后即刻,血浆肾素活性中位数较基线升高约3倍,在术后第0、1、2天仍保持升高,术后第3天开始下降。发生血管麻痹的患者在所有测量时间点的血浆肾素活性比未发生血管麻痹的患者高约3倍。
在接受体外循环心脏手术的患者中,血浆肾素活性术后升高,并在术后第2天持续升高。此外,接受体外循环心脏手术后发生血管麻痹综合征的患者血浆肾素活性升高幅度比未发生血管麻痹的患者更大。这些发现支持开展随机对照试验,以确定血浆肾素活性高的心脏手术患者是否可能从合成血管紧张素II等靶向治疗中获益。